

The Healthcare Professionals Alliance Against COVID-19, the alliance of more than 160 health professions organizations in the country, is alarmed that some Filipinos are receiving vaccines against COVID-19 that have not been registered with the Philippine Food and Drug Administration (FDA). In relation to this issue, there are three critical points of concern:
1. In keeping with public safety, we strongly discourage the use of vaccines that are not yet approved by the Philippine FDA.
2. Even if a vaccine is approved in other countries, its storage, transport, and distribution are complex procedures. Improper handling can damage vaccines and can render them useless. This is why distribution channels and processes need to be transparent and regulated.
Read more “HPAAC: A Call for Safe and Transparent Use of COVID-19 Vaccines” →
PCP-PSMID-HPAAC UNIFIED ALGORITHMS FOR COVID-19PCP-PSMID-HPAAC HPAAC Unified Algorithms for COVID-19 Speakers and Reactors: Lei Camiling Alfonso, MD Antonio Dans, MD Aileen Espina, MD Mario Panaligan, MD Maricar Limpin, MD Karin Estepa-Garcia, MD Ria Fajardo, MD Pauline Convocar, MD Moderator: Maaliddin Biruar, MD Apologyes as there is a typographical error on the title slide which should be COVID-19 instead of COVID-10. Thank you for your understanding!
Posted by Philippine Society for Microbiology and Infectious Diseases on Thursday, December 3, 2020
For any questions or information, please email covidrapidreviewteam@gmail.com.
clinical specimen pediatric abridged
>> Return to Rapid Reviews list.
For any questions or information, please email covidrapidreviewteam@gmail.com.
clinical outcomes pediatric Abridged
>> Return to Rapid Reviews list.
Dr. Jemelyn Garcia, FPCP, FPSMID
Dr. Maria Sonia Salamat, FPCP, FPSMID
Dr. Marja B. Buensalido, FPCP, FPSMID
Dr. Emmerson Gale Vista, FPDS
Dr. Clarisse Garcia-Mendoza, FPDS
Dr. Kingbherly L. Li, FPCP, FPSMID
Dr. Yvette Silubrico, FPCP, FPSMID
Dr. Chatie Olasiman, FPCP, FPSMID
Dr. Ma. Charmian Hufano, FPCP, FPSMID
Dr. Mitzie Lou Osabel, FPCP, FPSMID
Dr. Janice C. Caoili, FPCP, FPSMID
The Philippine Society for Microbiology and Infectious Diseases (PSMID) Guidance on the Management of Mpox, Ver. 1 provides the basic and most updated information on management of patients confirmed with mpox.
This guidance complements the mpox recommendations of the DOH (Updated Interim Guidelines on the Prevention, Detection, and Management of MPOX, by Department of Health, August 26, 2024, Department Memorandum 2024-0306) and PHICS-PHICNA (Interim Guidelines on the Prevention and Control of Monkeypox version 1).
The antivirals, immunoglobulin and vaccines discussed below are not available locally. In our local situation, we should maximize supportive care for mpox cases.